GREENLAND MINES LTD Allowance for Uncollectible Customer's Liability for Acceptances
GREENLAND MINES LTD (GRML) had Allowance for Uncollectible Customer's Liability for Acceptances of $0 as of 2025-04-04, per its 10-Q/A filed 2026-08-14.
Financial Statements › Notes › Financial Services
us-gaap:AllowanceForUncollectibleCustomersLiabilityForAcceptances · last filed 2026-08-14
- 2025-04-04: Allowance for Uncollectible Customer's Liability for Acceptances $0.00.
- 2025-01-03: Allowance for Uncollectible Customer's Liability for Acceptances $0.00.
- 2024-12-10: Allowance for Uncollectible Customer's Liability for Acceptances $0.00.
| Period end | Allowance for Uncollectible Customer's Liability for Acceptances |
|---|---|
| 2025-04-04 | $0.00 10-Q/A · filed 2026-08-14 |
| 2025-01-03 | $0.00 10-Q/A · filed 2026-08-14 |
| 2024-12-10 | $0.00 10-Q/A · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |